Mark Foletta, Interim CFO at Biocept, holds 0.00 shares in Biocept (Ticker: BIOCQ), holds 15.04K shares in Forte Biosciences (Ticker: FBRX), holds ― shares in Enanta Pharmaceuticals (Ticker: ENTA). Most recently, Mark Foletta ― shares of Biocept on ― for an estimated value of ―.